SAINTE-FOY, QUEBEC--(Marketwire - May 15, 2008) - Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced it has obtained an Investissement Quebec guarantee for a specific credit facility of $1 million granted by its financial institution. This credit is to be allocated to the financing of the Corporation’s export contracts subject to firm orders from its customers.
